The microbiome diversity in the lungs of cystic fibrosis (CF) patients increased after treatment with Trikafta, becoming similar…
Articles by Steve Bryson, PhD
For the first time, many features of cystic fibrosis (CF) were modeled accurately in a human Lung Airway Chip…
Scientists using phage therapy — specifically a bacteriophage they dubbed “Muddy” — successfully treated an infection by an antibiotic-resistant strain…
Vertex Pharmaceuticals has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA), which is an agreement in…
Researchers at the Children’s Hospital Colorado Breathing Institute are participating in four new studies to evaluate the long-term impact of…
Kaftrio successfully improved lung function and quality of life in three Italian cystic fibrosis (CF) patients who have severe…
Vertex Pharmaceuticals is initiating two Phase 3 clinical trials into the safety and efficacy of a potentially new, next-generation…
Most primary care providers (PCPs) in Ontario — family physicians, pediatricians, and midwives — voiced a willingness and confidence in…
Inflammation in the airways of people with cystic fibrosis (CF) regulates the pH of the surface liquid and increases…
Vertex Pharmaceuticals has reached reimbursement agreements with health authorities in France and Italy for its various cystic fibrosis (CF)…